231 related articles for article (PubMed ID: 11552264)
1. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
Sasaki T; Sasaki J; Suzuki A; Penninger JM
Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
[No Abstract] [Full Text] [Related]
2. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide signaling in urological disease.
Theodorescu D
J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
[No Abstract] [Full Text] [Related]
4. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
5. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
Ott VL; Cambier JC
Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
[No Abstract] [Full Text] [Related]
6. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
Kurlawalla-Martinez C; Stiles B; Wang Y; Devaskar SU; Kahn BB; Wu H
Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
[TBL] [Abstract][Full Text] [Related]
7. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
Paez J; Sellers WR
Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
[No Abstract] [Full Text] [Related]
8. [Genetic abnormalities in endometrial cancer].
Takeshima N; Hirai Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
[No Abstract] [Full Text] [Related]
9. [Receptor tyrosine kinases (c-kit, c-fmns, Flt-3, Tie2, etc.)].
Yoshimura A; Sanada M; Mashima R
Nihon Rinsho; 2005 Apr; 63 Suppl 4():207-14. PubMed ID: 15861658
[No Abstract] [Full Text] [Related]
10. [Topics on gene abnormality in endometrial cancer].
Shiozawa T; Konishi I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
[No Abstract] [Full Text] [Related]
11. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
[TBL] [Abstract][Full Text] [Related]
12. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
13. Stem cells. PTEN--coupling tumor suppression to stem cells?
Penninger JM; Woodgett J
Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
[No Abstract] [Full Text] [Related]
14. Phosphatidylinositol 3-kinase, phosphoinositides and apoptosis. Polyphosphoinositol phosphatase and apoptosis.
Sarmay G
Subcell Biochem; 2002; 36():309-33. PubMed ID: 12037988
[No Abstract] [Full Text] [Related]
15. Phosphoinositide phosphatases in a network of signalling reactions.
Blero D; Payrastre B; Schurmans S; Erneux C
Pflugers Arch; 2007 Oct; 455(1):31-44. PubMed ID: 17605038
[TBL] [Abstract][Full Text] [Related]
16. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
17. Restraining PI3K: mTOR signalling goes back to the membrane.
Harrington LS; Findlay GM; Lamb RF
Trends Biochem Sci; 2005 Jan; 30(1):35-42. PubMed ID: 15653324
[TBL] [Abstract][Full Text] [Related]
18. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
19. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling.
Vinciguerra M; Foti M
Arch Physiol Biochem; 2006 Apr; 112(2):89-104. PubMed ID: 16931451
[TBL] [Abstract][Full Text] [Related]
20. PI 3-kinases and PTEN: how opposites chemoattract.
Comer FI; Parent CA
Cell; 2002 May; 109(5):541-4. PubMed ID: 12062096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
